Quote For Quest Diagnostics, Inc. DGX.N
Quest Diagnostics, Inc. (DGX.N) (New York Stock Exchange)
sector: Healthcare ·
industry: Healthcare Facilities ·
$57.75
3 Dec 2009
-1.50%
$57.75
--
835,169
$58.78
$57.65
$59.57
$42.36
0.38
930,613
News
Press Releases
Key Developments
Officers
| Name | Current Position | Compensation |
|---|---|---|
| Mohapatra, Surya | Chairman of the Board, President, Chief Executive Officer | 11,964,632 |
| Hagemann, Robert | Chief Financial Officer, Senior Vice President | 4,124,174 |
| Prevoznik, Michael | Senior Vice President, General Counsel | 2,360,802 |
Key Ratios and Statistics
| Share Related Items | |
|---|---|
| Market Cap (Mil.) | $10,678.01 |
| Shares Outstanding (Mil.) | 184.90 |
| Float (Mil.) | 149.50 |
| Dividend Information | |
|---|---|
| Yield % | 0.69 |
| Annual Dividend ($ USD) | 0.40 |
| Payout Ratio(TTM) % | 10.42 |
| Financial Strength | |
|---|---|
| Quick Ratio | 1.14 |
| Current Ratio | 1.48 |
| LT Debt/Equity | 73.55 |
| Total Debt/Equity | 76.20 |
| Valuation Ratios | |
|---|---|
| Price/Earnings(TTM) | 15.25 |
| Price/Sales(TTM) | 1.44 |
| Price/Book(TTM) | 2.73 |
| Price/Cash Flow(TTM) | 10.62 |
| Per Share Data | |
|---|---|
| Earnings(TTM) | $3.82 |
| Sales(TTM) | $39.01 |
| Book Value(MRQ) | $21.17 |
| Cash Flow(TTM) | $5.30 |
| Cash(MRQ) | $1.34 |
| Management Effectiveness | |
|---|---|
| Return on Equity(TTM) | 18.79 |
| Return on Assets(TTM) | 8.81 |
| Return on Investment(TTM) | 10.17 |
| Margins | |
|---|---|
| Gross Margin(TTM) % | 42.05 |
| Operating Margin(TTM) % | 18.17 |
| Profit Margin(TTM) % | 10.08 |
Market Update
UK
US- Europe
- Asia
- UK Most Actives
advertisement
